Treatment Information

Back

Brain – Glioblastoma Multiforme treatment details. Chemotherapy, Radiation, Biologic therapy.

University of Colorado School of Medicine, Aurora, CO, United States.

Survival: monthsCountry:United States
Toxiciy Grade:5City/State/Province:Aurora, CO
Treatments:Chemotherapy, Radiation, Biologic therapyHospital:University of Colorado School of Medicine
Drugs:Journal:Link
Date:Dec 2014

Description:

Patients:
This phase 2 study involved 30 glioblastoma patients who were newly diagnosed. The median patient age was 57 years and 17 were male.

Treatment:
Patients received radiation therapy, chemotherapy with temozolomide, and biologic therapy with bevacizumab.

Toxicities:
Treatment-related deaths due to infection and sudden death were reported. Grade 3/4 neutropenia, fatigue, and stroke were also reported.

Results:
The median overall survival was 16.3 months.

Support:
This study was partially supported by Genentech (makers of bevacizumab).

Correspondence: Dr. Douglas E. Ney ; email: [email protected]



Back